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Abstract
A growing number of studies focusing on the developmental origin of health and disease hypothesis have identified links among early
nutrition, epigenetic processes and diseases also in later life. Different epigenetic mechanisms are elicited by dietary factors in early critical
developmental ages that are able to affect the susceptibility to several diseases in adulthood. The studies here reviewed suggest that
maternal and neonatal diet may have long-lasting effects in the development of non-communicable chronic adulthood diseases, in particu-
lar the components of the so-called metabolic syndrome, such as insulin resistance, type 2 diabetes, obesity, dyslipidaemia, hypertension,
and CVD. Both maternal under- and over-nutrition may regulate the expression of genes involved in lipid and carbohydrate metabolism.
Early postnatal nutrition may also represent a vital determinant of adult health by making an impact on the development and function of
gut microbiota. An inadequate gut microbiota composition and function in early life seems to account for the deviant programming of later
immunity and overall health status. In this regard probiotics, which have the potential to restore the intestinal microbiota balance, may be
effective in preventing the development of chronic immune-mediated diseases. More recently, the epigenetic mechanisms elicited by pro-
biotics through the production of SCFA are hypothesised to be the key to understand how they mediate their numerous health-promoting
effects from the gut to the peripheral tissues.
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Introduction
During the last few years, a growing number of studies
focusing on the developmental origin of health and disease
have identified links among early nutrition, epigenetic pro-
cesses and diseases also in later life. There is convincing
experimental evidence to suggest that epigenetic marks
serve as a memory of exposure in early life to inadequate
or inappropriate nutritional factors. These marks induce
long-term changes in gene expression, potentially leading
to diseases in adulthood, according to the ‘developmental
origin of health and disease’ (known as DOHaD) hypoth-
esis(1–3). Epigenetic modifications may be one mechanism
by which exposure to an altered intra-uterine milieu or
metabolic perturbation may influence gene expression
and modulate the phenotype of the organism much later
in life(4). Exposures during early life may be critical, as
the plasticity of growing and developing tissues means
that they shape the way in which the body responds to
later challenges.
The purpose of this review is to present the latest scien-
tific data suggesting that nutrition in early life could be con-
sidered as an important risk factor for non-communicable
diseases of adulthood. In this regard, the role of intestinal
microflora and its metabolites, such as SCFA and especially
butyrate, will be addressed. Probiotics are largely used in
human nutrition, especially in the paediatric age. Many
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infant formulas, and other baby food products contain
probiotics. The possible presence of probiotic strains
even in human milk is debated too. It is hypothesised
that the biological function of probiotics may be the
result of epigenetic modifications that may explain the
wide range of the observed effects.
Epigenetic mechanisms elicited by nutritional factors
Epigenetics encompasses changes to marks on the genome
that are copied from one cell generation to the next, which
may alter gene expression, but which do not involve
changes in the primary DNA sequence. There are three
distinct, but closely inter-acting, epigenetic mechanisms
possibly elicited by nutritional factors (Table 1). They
include DNA methylation, histone modifications and non-
coding microRNAs (miRNA; short RNA molecules) which,
together, are responsible for regulating the intensity and
the timing of expression of specific genes, not only
during cellular differentiation in embryonic and fetal devel-
opment but also throughout the life-course(5,6).
Effects of nutritional factors on DNA methylation
Changes in DNA methylation are an essential part of
normal development. Nutritional factors can change DNA
methylation of gene specific promoters, which are closely
associated with gene expression. A proportion of the cyto-
sine residues is modified after translation by attachment of
a methyl group to position 5 on the cytosine ring. Such
methylated cytosines are usually found where the cytosine
is next to a guanine residue, i.e. in a cytosine–phosphate–
guanine (CpG) dinucleotide. In about half the genes of
human genome, unmethylated CpG are found clustered
at the 50 ends of genes in domains known as CpG islands.
When the CpG in such islands are unmethylated, gene
transcription proceeds normally but when some or all of
the CpG become methylated, the genes are switched off(7).
Folate has been extensively studied for its effect on DNA
methylation, because folate carries a methyl group and
ultimately delivers this methyl group for the synthesis of
adenosyl methionine (AdoMet), the unique methyl donor
for DNA methylation reactions. However, folate is not the
unique determinant of DNA methylation, because other
methyl donor nutrients such as methionine, choline,
betaine, and vitamins B2, B6 and B12 can also change
DNA methylation status(8). Because folate deficiency
during pregnancy is associated with an increased risk of
neural tube defects, aberrant reprogramming of DNA meth-
ylation by low dietary folate has been suggested as a can-
didate mechanism. In an animal study, restriction of folate,
vitamin B12 and methionine from the periconceptional diet
induced obesity in adult offspring and an altered immune
responses to an antigenic challenge(9). However, pericon-
ceptional supplementation of folic acid is associated with
imprinting status of insulin-like growth factor 2 in the
child, which may affect intra-uterine growth with potential
consequences in adulthood as illustrated by the association
between higher insulin-like growth factor 2 methylation
and decreased birth weight(10). Choline and betaine, two
donors of methyl groups, have been studied for their
role upon brain development and function. Zeisel(11)
demonstrated that choline availability during fetal brain
development induces epigenetic changes that can finely
modulate the expression of genes with specific roles in
neuronal differentiation and angiogenesis in the fetal hip-
pocampus(11,12). Dietary restriction in methyl donors as
well as genetic polymorphisms in folate metabolism have
Table 1. Epigenetic roles of main nutritional factors and type of diets
Nutritional factors (natural source) and diet Epigenetic mechanisms
Main physiological and
clinical effects References
Butyrate (fermentation of dietary fibre) Histone modifications Cancer prevention and therapy;
anti-inflammatory
Wiedmeier et al.(55)
Betaine (grain products and vegetables
such as spinach and beets) Choline
(red meat, poultry, milk, eggs)
DNA methylation Fetal brain development
and function
Sinclair et al.(10), Zeisel(11),
Mehedint et al.(12),
Kanai & Hirohashi(13)
Curcumin (turmeric) MicroRNAs Cancer prevention and therapy Salerno et al.(22), Sun et al.(23)
Diallyl disulfide (garlic) Histone modifications Cancer prevention Ficz et al.(15), Delage &
Dashwood(16)
High-cholesterol diet MicroRNAs Obesity Pogribny et al.(26)
High-fat diet DNA methylation Obesity; metabolic syndrome Buckley et al.(45),
Khan et al.(46,47)
Dietary methyl deficiency MicroRNAs Non-alcoholic steatohepatitis;
liver cancer
Weiss et al.(25)
Dietary protein restriction DNA methylation;
histone modifications
Impaired glucose metabolism;
type 2 diabetes
Armitage et al.(31,32),
Cianfarani et al.(40)
Folic acid (leafy vegetables, nuts, sunflower, seeds) DNA methylation Embryonic development Steegers-Theunissen et al.(9)
Genistein (soya) MicroRNAs Cancer prevention and therapy Iorio et al.(21)
Retinoic acid (carrots, spinach, eggs) Histone modifications;
microRNAs
Cancer prevention and therapy Yang et al.(24)
Sulforaphane (broccoli) Histone modifications Cancer prevention Ficz et al.(15),
Delage & Dashwood(16)
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been associated with abnormal DNA methyltransferase
expression, global DNA hypomethylation and increased
cancer risk(13). Using the agouti viable yellow (Avy)
mouse model, Waterland(14) have also shown that methyl
donor supplementation prevents transgenerational amplifi-
cation of obesity through three generations, suggesting a
role for DNA methylation in the developmental establish-
ment of body-weight regulation. All these studies suggest
that DNA methylation induced by nutritional factors in
early life could play a critical role in development regu-
lation not only during the fetal period but also throughout
the life-course. The new research reveals that a new type
of epigenetic modification, 5-hydroxymethylcytosine,
plays a critical role mediating the external signals that
instruct a cell how to develop. Hydroxymethylation
appears to be linked to a higher degree of pluripotency,
and the balance between hydroxymethylation and
methylation in the genome is inextricably linked with the
balance between pluripotency and lineage commitment.
This new epigenetic mark, hydroxymethylation, might
help with developing improved strategies for regenerative
medicine(15).
Effects of nutritional factors on histone modifications
In contrast to DNA that is modified only by methylation,
histones can be modified by methylation, acetylation,
phosphorylation, biotinylation, ubiquitination and ADP-
ribosylation, which are different types of chemical modifi-
cations mainly located within the N-terminal tails of core
histones. Histone acetylation is one of the most extensively
studied epigenetic mechanisms. Histone tail acetylation is
believed to enhance the accessibility of a gene to the
transcription machinery, whereas deacetylated tails are
highly charged and believed to be tightly associated with
the DNA backbone, thus limiting accessibility of genes to
transcription factors(16). Interestingly, histone deacetylase
(HDAC) inhibitors have been recognised as new potential
therapeutic drugs against cancer, because they induce cell
cycle arrest and apoptosis by enhancing the expression of
certain pro-apoptotic or cell cycle-mediating genes. Recent
interest in HDAC inhibitors has expanded into the realm of
cancer chemoprevention, as distinct from cancer therapy,
with evidence that dietary compounds such as butyrate,
diallyl disulfide and sulforaphane act as weak ligands for
HDAC and exhibit HDAC inhibitory activity. The working
hypothesis for dietary agents is that DNA/chromatin inter-
actions are kept in a constrained state in the presence of
HDAC/co-repressor complexes, but HDAC inhibitors
enable histone acetyltransferase/co-activator (HAT/CoA)
complexes to transfer acetyl groups to lysine ‘tails’ in his-
tones, thereby loosening the interactions with DNA and
facilitating transcription factor access and gene activation.
Among the epigenetically silenced genes that have
received particular interest are p21 and bax due to their
implications for cell cycle arrest and apoptosis, and
because they are among a select cadre of genes frequently
repressed in cancer cells and de-repressed following treat-
ment with HDAC inhibitors.
Different dietary agents such as butyrate, biotin, lipoic
acid, garlic organosulfur compounds, and metabolites of
vitamin E have structural features compatible with HDAC
inhibition. The ability of dietary compounds to de-repress
epigenetically silenced genes in cancer cells, and to
activate these genes in normal cells, has important
implications for cancer prevention and therapy(17). In a
broader context, there is growing interest in dietary
HDAC inhibitors and their impact on epigenetic mechan-
isms affecting other chronic conditions, such as CVD,
neurodegeneration and ageing.
Effects of nutritional factors on microRNAs
RNA is not only a messenger operating between DNA and
protein. Transcription of the entire eukaryotic genome gen-
erates a myriad of non-protein-coding RNA species that
show complex overlapping patterns of expression and
regulation. miRNA are small RNA molecules encoded
in the genome that can have a profound effect in control-
ling gene expression. miRNA bind to their target mRNA
and down-regulate their stabilities and/or translation.
Each miRNA is predicted to have many targets, and
each mRNA may be regulated by more than one
miRNA(18,19). miRNA can play important roles in controlling
DNA methylation and histone modifications, creating a
highly controlled feedback mechanism(20). Interestingly,
epigenetic mechanisms such as promoter methylation or
histone acetylation can also modulate miRNA expression.
A relationship between epigenetics and miRNA has been
found to play important roles in carcinogenesis by altering
cell proliferation and apoptosis(21). Curcumin, genistein
and retinoic acid are bioactive food components which
are able to reduce carcinogenesis through miRNA(22–25).
More recently, it has been suggested that miRNA are
involved not only in carcinogenesis, but also in the genesis
of insulin resistance and other related disorders. Animal
models of methyl-deficient diet suggest that alterations
in the expression of miRNA are a fundamental event
during the development of liver cancer and non-alcoholic
steatohepatitis induced by dietary methyl deficiency(26).
Alterations of miRNA are also observed in pigs fed a
high-cholesterol diet compared with those fed a standard
diet, indicating the potential implications of miRNA in
obesity(27). Although long non-coding RNA are among
the least well understood of non-protein-coding RNA
species, they cannot all be dismissed as merely transcrip-
tional ‘noise’. Recent evidence suggests their roles in
transcriptional regulation, epigenetic gene regulation and
diseases(28). In this area, more studies are needed to evalu-
ate the therapeutic potential of epigenetic modifiers and
non-protein-coding RNA species.
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Epigenetic mechanisms elicited by maternal diet during
pregnancy
Epidemiological and experimental data obtained in animal
models(29–32) show that both under- and over-nutrition
during pregnancy and/or lactation induce stable alterations
to the physiological and structural phenotype of the off-
spring. Studies in animal models have used a candidate
gene approach to identify the molecular basis for changes
in activities of metabolic and endocrine pathways, with a
specific focus on corticosteroid activity, and carbohydrate
and lipid metabolism.
In rats moderate maternal dietary protein restriction is
known to alter phenotypes in the offspring, which mani-
fests as hypertension, dyslipidaemia and impaired glucose
metabolism. However, these abnormalities can be reversed
by folate supplementation. It has been shown that the
induction of an altered phenotype by a maternal protein-
restricted diet during pregnancy involves changes in DNA
methylation and histone modifications in specific genes,
including the glucocorticoid receptor (33 % lower;
P,0·001) and PPARa (26 % lower; P,0·05) in the liver
of juvenile and adult offspring(33,34), as well as hepatocyte
nuclear factor 4a (Hnf4a) in pancreatic islets(35). However,
a high protein intake in rats during pregnancy and lactation
also results in male offspring with higher blood pressure
and female offspring with higher body mass and increased
fat pad mass; it is possible to speculate that these effects
are also mediated by epigenetic mechanisms(36).
Maurer & Reimer(37) showed that a maternal high-
protein diet, but not high-prebiotic fibre diet, during
pregnancy and lactation could negatively influence the
expression of genes involved in glucose and lipid metab-
olism in the offspring rats. These early changes, perhaps
based on epigenetic mechanisms, could have long-term
consequences for the development of obesity and the
metabolic syndrome(37).
Interestingly, a number of clinical studies have shown
that the highest risk for development of the metabolic syn-
drome and diabetes occurs in adults who are born small
for gestational age and become overweight in early child-
hood. The association between low birth weight and
early postnatal catch up growth with late onset of disease
is due to very early development of insulin resist-
ance(38–40). In experimental animal studies there is
evidence that prenatal under-nutrition causes alteration in
pancreatic islet neogenesis, impairing the capacity of
b-cell regeneration(41). This may explain the inability of
b-cell mass to adapt during ageing, which aggravates
glucose tolerance. The rat model of protein restriction
showed that maternal low-protein diet results in increased
susceptibility to insulin resistance in the offspring and that
this effect was attributed to reduced b-cell mass due to
lower cell proliferation(42). Pinney & Simmons(43) studied
epigenetic events at the promoter of the gene encoding
pancreatic and duodenal homeobox 1 (Pdx-1), a critical
transcriptional factor for b-cell function and development,
the expression of which is reduced in intra-uterine
growth retardation (IUGR), promoting the development
of diabetes in adulthood. IUGR resulted in transcriptional
repression of Pdx-1 due to histone deacetylation and a
consequent loss of binding of major transcription factors
to the Pdx-1 promoter. At the neonatal stage, this epige-
netic process is reversible and may define an important
developmental window for therapeutic approaches. After
birth, histone deacetylation progresses and is followed by
a marked decrease in histone H3 lysine 4 (H3K4) trimethy-
lation and a significant increase in dimethylation of histone
H3 lysine 9 (H3K9) in IUGR islets. H3K4 trimethylation is
usually associated with active gene transcription, while
H3K9 dimethylation is usually a repressive chromatin
mark. Progression of these histone modifications parallels
the progressive decrease in Pdx-1 expression which
locks in the silenced state in the IUGR adult pancreas
resulting in diabetes(43). Similarly, Raychaudhuri et al.(44)
demonstrated that perinatal nutrient restriction resulting
in IUGR leads to histone modifications in skeletal muscle
that directly decrease GLUT type 4 (Glut4) gene
expression. This effectively creates a metabolic knock-
down of this important regulator of peripheral glucose
transport and insulin resistance, thereby contributing to
adult type 2 diabetes(44).
Besides prenatal under-nutrition models, the metabolic
intra-uterine environment may also be modified in the
case of prenatal over-nutrition. There is evidence that
increased dietary fat intake during pregnancy and lactation
predisposes the offspring to develop a metabolic syn-
drome-like phenotype in adult life. It has been found
that maternal high fat feeding results in the offspring
having exacerbated adiposity and modified expression of
key proteins involved in hepatic insulin sensitivity(45).
These offspring also develop endothelial, cardiovascular
dysfunction and sex-specific hypertension(46,47).
Maternal fat intake contributes toward non-alcoholic
fatty liver disease progression in adult offspring, which is
mediated through impaired hepatic mitochondrial metab-
olism and up-regulated hepatic lipogenesis. It is plausible
to speculate that suboptimal nutrition during the develop-
mental period may alter the epigenetic profile of key
genes, subsequently leading to persistent modulation in
gene transcription and increasing the risk of developing
non-alcoholic steatohepatitis in adulthood(48). Perinatal
exposure to high-fat, high-sugar diets also results in altered
development of the central mesolimbic reward system.
These offspring exhibit increased preference for fat, lead-
ing to suggestions that perinatal exposure to high-fat,
high-sugar foods results in permanent changes within the
central reward system that increase the subsequent drive
to overconsume palatable foods in postnatal life(49).
Recent evidence indicates that JmjC-domain-containing
histone demethylase 2A (JHDM2a), which catalyses removal
of H3K9 mono- and dimethylation through Fe- and
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a-ketoglutarate-dependent oxidative reactions, regulates
metabolic genes related to energy homeostasis including
anti-adipogenesis, regulation of fat storage, glucose
transport and type 2 diabetes. Mice deficient in JHDM2a
develop adult-onset obesity, hypertriacylglycerolaemia,
hypercholesterolaemia, hyperinsulinaemia and hyperlepti-
naemia, which are hallmarks of the metabolic syndrome.
JHDM2a2/2 mice furthermore exhibit fasted-induced
hypothermia indicating reduced energy expenditure and
also have a higher RQ indicating less fat utilisation for
energy production. These observations may explain the
obesity phenotype in these mice. Thus, H3K9 demethylase
JHDM2a is a crucial regulator of genes involved in energy
expenditure and fat storage, which suggests that it rep-
resents a previously unrecognised key regulator of obesity
and the metabolic syndrome(50).
Diabetic patients continue to develop inflammation and
vascular complications, even when glycaemia is controlled.
This process is attributed to a ‘hyperglycaemic metabolic
memory’ based on epigenetic mechanisms. Brasacchio
et al.(51) shows that periods of transient or prior hypergly-
caemia lead to various methylation and demethylation
events that, when integrated, have an impact on gene
activity. These events lead to sustained activation of pro-
inflammatory pathways, which are likely to participate in
the progression of diabetic complications. Further under-
standing of the chromatin remodelling events and how
they are linked to ongoing vascular changes in diabetes
should lead to better strategies to reduce the burden of
diabetes complications(51).
Microbiota, epigenetics and early postnatal nutrition
It is now becoming clear that the early postnatal environ-
ment, including nutrition, is also a vital determinant of
adult health (Fig. 1). Environmental exposures such as
early infant diet are believed to make an impact on the
development and function of gut microbiota(52). The intes-
tinal microbiota plays a critical role in the establishment
and maintenance of healthy immune responses. Delayed
colonisation of the infant gut with commensal bacteria
or alterations in the microbiota profile are suggested
to be strong risk factors for the development of immune-
mediated chronic disorders such as allergic and auto-
immune diseases(53). Solid scientific arguments suggest
that immune deviances later in life could be the conse-
quence of an inadequate bacterial pressure on the intesti-
nal mucosa at the early stage. A variety of epigenetic
modifications taking place in this early stage could account
for the deviant programming of later immunity and overall
Chromosome
Chromatin
DNA
Epigenetic factors
Epigenetic mechanisms
DNA methylation
Histone modification
Non-coding microRNA
Health endpoints
Diabetes
Obesity
Hypertension
Dyslipidaemia
CVD
Fig. 1. The potential role of maternal diet on the development of the metabolic syndrome. Different epigenetic mechanisms may be involved in the long-lasting
effects elicited by dietary factors in the development of the main components of the metabolic syndrome: diabetes, obesity, hypertension, dyslipidaemia and CVD.
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health status (Fig. 2) (54). While the role of epigenetics in
postnatal programming of the neonate remains to be
demonstrated, there appears to be a window in which
infants are vulnerable(55). Restoring the microbiota profile
with a single bacteria species may be effective in the pre-
vention or treatment of allergic and inflammatory diseases,
but only if this occurs during the neonatal period. These
observations have led to the idea that probiotics, which
have the potential to restore the intestinal microbiota bal-
ance, may be effective in preventing the development of
chronic immune-mediated diseases(53). A probiotic is
defined as a living micro-organism which when adminis-
tered in adequate amounts confers a health benefit on
the host(56). The exact mechanisms of action for probiotic
bacteria have yet to be fully understood, but it is hypoth-
esised that the biological function of probiotics may be a
result of epigenetic modifications that may explain the
wide range of the observed effects. An important role for
probiotic bacteria is the fermentation of dietary com-
pounds leading to production of SCFA. Studies delineating
the effects of probiotics on SCFA production and the epi-
genetic actions of SCFA will assist in understanding the
association between microbiota and allergic or auto-
immune disorders. The SCFA butyrate, a main endproduct
of microbial fermentation of dietary fibres in the human
intestine, plays an important role in the maintenance of
intestinal homeostasis and overall health status. The effects
exerted by butyrate are multiple from the gut to the periph-
eral issues with a high potential for a therapeutic use
in human medicine(57). Butyrate is part of a class of
epigenetic factors known as HDAC inhibitors, with
several functions such as anti-inflammatory and anti-
carcinogenesis effects. Given the role of bacterial species
in the production of SCFA, probiotics may be considered
as an alternative approach for the prevention or treatment
of chronic inflammatory diseases(53). Intestinal microflora
recently also has been implicated in the development of
some metabolic phenotypes, such as obesity and insulin
resistance(58). A longitudinal, prospective study in child-
hood revealed that a combination of early exposures,
including delivery mode (vaginal v. by caesarean section),
maternal pre-pregnancy BMI and antibiotics in infancy
(less than 6 months of age), influences the risk of over-
weight in childhood, evaluated with a follow-up at age 7
years. This effect may potentially be explained by an
impact on establishment and diversity of the microbiota(59).
Recently, Wang et al.(60) identified a new direct link
between gut flora-dependent metabolism of dietary phos-
phatidylcholine and CVD pathogenesis, which represents
the leading cause of death and morbidity worldwide.
These results indicate that an appropriately designed pro-
biotic intervention may serve as a therapeutic strategy for
the prevention and treatment of atherosclerotic heart dis-
ease and its complications(60). In this regard, it will be
important to evaluate in animal models of postnatal dietary
manipulation the effects of specific nutrients on methyl-
ation and histone modifications, considering that some of
the benefits attributed to breast milk may partly be due
to the establishment of a beneficial bacterial flora in the
gut of milk-fed infants, whichever the origin(61).
Conclusions
The studies reviewed here suggest that maternal and neo-
natal diet may have long-lasting effects in the development
of non-communicable chronic adulthood diseases, in
particular the components of the so-called metabolic
syndrome, such as insulin resistance, type 2 diabetes,
obesity, dyslipidaemia, hypertension and CVD. Different
epigenetic mechanisms may, at least in part, explain the
way by which dietary factors in early critical developmen-
tal steps might be able to affect the susceptibility to
develop metabolic diseases in adulthood. Both maternal
under- and over-nutrition may interact with genes control-
ling lipid and carbohydrate metabolism, thus inducing
alterations in epigenetic regulations. Early postnatal
environment, including nutrition, may represent a vital
determinant of adult health by making an impact on
the development and function of gut microbiota. The
epigenetic mechanisms elicited by probiotics through the
production of SCFA are hypothesised to be the key to
understand how they mediate their numerous health-
promoting effects from the gut to overall health status.
Much of the recent progress in understanding epigenetic
phenomena is directly attributable to technologies that
allow researchers to pinpoint the genomic location of pro-
teins that package and regulate access to DNA. However,
despite recent advances, our knowledge regarding nutri-
tional epigenetics in early life is still limited. Further studies
in human subjects using the latest technologies are
needed to better understand the use of nutrients or bio-
active food components for maintaining our health
and preventing diseases through modifiable epigenetic
Early nutrition
Intestinal microflora
Epigenetic
regulation of gene
expression
Genetic programming
Offspring phenotype
Fig. 2. Offspring phenotype is influenced by genetic programming and
by epigenetic regulation of gene expression, elicited by prenatal/neonatal
nutrition and intestinal microflora composition in early life.
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mechanisms. Moreover, given the plasticity of epigenetic
marks and their responsiveness to dietary factors, there is
potential for the development of epigenetic marks as bio-
markers of health for use in intervention studies.
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